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Abstract 
Context: Hospital workers are at risk of genotoxic damage following occupationally exposure 
to xenobiotics.  
Objective: we evaluated the level of genomic damage in a sample of hospital pathologists. 
Materials and Methods: Lymphocytes were analysed by SCEs and CAs assays and 
genotyped for six metabolic and DNA-repair gene polymorphisms. 
Results: Pathologists showed significantly higher levels of cytogenetic damage with respect 
to control subjects. GSTT1 null, XPD 751 CC and XPC 939 CC genotypes were found to be 
associated with higher frequency of SCEs. 
Discussion and Conclusion: These higher levels of SCEs could be explained by a lower DNA 
repair efficiency in C-allele carrier subjects. Our data evidenced that pathologists are a 
category at risk of genotoxic damage, further confirming the importance of the genetic 
polymorphisms analysis associated to genotoxicological studies.  
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Introduction 
Hospital workers can be considered a category at risk of genotoxic damage following 
exposure to a variety of environmental xenobiotics. For example, it has been showed that 
anaesthetists, radiologists and nurses are chronically exposed in their work routine to 
different chemical and/or physical pollutants, although at low doses (Santovito et al., 2014 
a,b; Santovito et al., 2011; Kopjar et al., 2009). 
However, beyond these known risk groups, there are other less studied hospital workers 
categories at risk of genomic damage from exposure to xenobiotics. Among these, the 
pathologists represent workers chronically exposed, for professional reasons, to low doses of 
different environmental xenobiotics such as drugs, formaldehyde and ethylene oxide. These 
last two compounds, principally used for sterilization, are well-known human carcinogens 
(IARC, 2006, 2007) and are related to higher levels of genomic damage among exposed 
subjects (Lorenti et al., 2001; Donner et al., 2010; Santovito et al., 2011). 
In this scenario, the use of biomonitoring processes among hospital personnel with potential 
occupational risks, is of primary interest in biological safety. 
In the present study, we evaluated the level of the genomic damage in peripheral blood 
lymphocytes from hospital pathologists using two different cytogenetic biomarkers, sister 
chromatid exchanges (SCEs) and chromosomal aberrations (CAs), which are considered 
indicators of genomic instability and early biological effects of carcinogenic exposure, 
respectively. SCEs occur as consequence of reciprocal changes between DNA replication 
products at apparently homologous chromosomal loci. Increased levels of SCEs are related to 
defects in the DNA-repair machinery (Garcia-Sagredo, 2008). On the other hand, the CAs 
assay allows a rapid detection of cells carrying unstable aberrations (i.e. chromosome and 
chromatid breaks, fragments, rings and dicentrics) that will lead to cell death during 
proliferation (Garcia-Sagredo, 2008). It has been showed that a high CAs frequency in 
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peripheral blood lymphocytes represents a powerful predictor of cancer risk (Bonassi et al., 
2004). 
It is known that the level of the genomic damage due to environmental or occupational 
exposure to different chemicals also depends on the different individual susceptibility. From 
genetic point of view, this susceptibility is due to polymorphisms in a battery of genes, 
principally metabolic genes (such as cytochrome P (CYP) 450 and glutathione- S-transferase 
(GST) family genes) and DNA-repair genes (Autrup H, 2000; Wang et al., 2013). Phase I 
cytochrome P450 (CYP1) gene products are involved in the oxidative metabolism of 
xenobiotics, producing compounds subsequently processed by phase II enzymes, such as 
GSTT1. At the same time, in order to prevent the potentially mutagenic consequences of 
DNA modifications, cells have evolved different mechanisms of DNA repair, depending on 
the specific type of DNA damage. These mechanisms include Base Excision Repair (BER) 
and Nucleotide Excision Repair (NER) that correct non-bulky damage and lesions that distort 
the DNA double helical structure, respectively (Cleaver et al., 2009; Collins and Azqueta, 
2012). DNA-repair genes, being responsible for preventing the integrity of the genome, are 
considered as cancer-susceptibility genes (Khlifi et al., 2012) and a reduced repair capacity 
has been reported to be associated with cancer development (McHugh et al., 2001; Berwick 
and Vineis, 2000). 
On the basis of these assumptions, we also decided to evaluate the relationships between 
some of the commonly studied phase I (CYP1A1 Ile/Val), phase II (GSTT1 and GSTM1) and 
DNA-repair (XPD 751 A>C and XPC A939C) gene polymorphisms and the levels of 
genomic damage measured by SCEs and CAs assays. 
The CYP1A1 gene product catalyzes the initial conversion of many environmental 
carcinogens, such as aromatic hydrocarbons. Several polymorphisms are known for CYP1A1 
gene, among which a point mutation (A>G) at codon 462 of exon 7 replaces an isoleucine 
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(CYP1A1*1A allele) with a valine (CYP1A1*2C allele). In some populations this amino acid 
substitution has been shown to be associated with higher risks for certain types of cancer 
(Chen et al., 2001).  
 
GSTT1 enzyme has both detoxifying and activating properties in many environmental 
pollutants. In humans GSTT1 gene is polymorphic for a DNA deletion resulting in the 
absence of protein synthesis and consequent reduced detoxification of xenobiotics in 
homozygous individuals. This deletion polymorphism for the GSTT1 gene has been found to 
be associated with the development of some types of cancer (Huafroid et al., 2007), as well as 
to an increased susceptibility to DNA damage (Santovito et al., 2015).  
 
DNA repair genes play critical roles in response to carcinogen-induced DNA damage.  
Xeroderma pigmentosum complementation group D (XPD) and xeroderma pigmentosum 
complementation group C (XPC) are two genes involved in the NER pathway. XPD enzyme 
remove adducts caused by environmental agents, UV-induced DNA damage, crosslinks and 
oxidative damage (Ma et al., 2013). Point mutations in the XPD gene can diminish the 
helicase activity, resulting in a defect in NER (Winkler et al., 2000) and in an abnormal 
response to apoptosis (Taylor et al., 1997). In particular, the XPD codon 751 CC genotype 
was found to be associated with defective repair of UV-induced DNA damage and higher 
levels of chromatid-type aberrations (Au et al., 2004).  
Finally, XPC gene is critical for the cells to complete excision repair of bulky DNA lesions, 
(Berneburg and Lehmann, 2001). XPC protein binds to HR23B, forming the XPC-HR23B 
complex involved in in the earliest damage detection and initiation of NER (Sugusawa et al., 
1998). Among XPC polymorphisms, the A>C transition at codon 939 of exon 15, resulting in 
a Lys>Gln alteration, was found to have an influence on the DNA repair rates in peripheral 
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lymphocytes (Vodicka et al., 2004) and was found to be associated with increased risk of 
bladder cancer (Senyal et al., 2004) and breast cancer (Forsti et al., 2004). 
 
 
 
 
 
Methods 
Study Population 
The study included 61 hospital pathologists working in two hospital departments and 60 
control subjects belonging to the administrative staff of the same hospitals but without any 
work-related exposure to hazardous agents. All exposed subjects declared to use complete 
protective equipment, according to the Italian guidelines and were routinely tested for urinary 
and blood drugs concentrations. Among pathologists, the lack of data about the individual 
exposure doses is because the majority of the workers enrolled in this study are exposed to a 
variety of different xenobiotics and did not use dosimeters.  
It is known that drugs, radiations, smoking and alcohol consumption could influence the 
levels of cytogenetic damage (Santovito et al., 2014 a,b; 2015; Sierra-Torres et al., 2004). For 
these reasons, in our sample, we exclusively considered individuals who have not smoked nor 
consumed alcohol and drugs and have not been subjected to diagnostic examinations for a 
period of at least 2 years prior to the analysis. All the subjects were healthy volunteers and 
received information about the study. The procedures followed in this work were approved 
by the local responsible committee on human experimentation and have been performed in 
accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. 
 
Blood Sample Collection 
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Blood samples were obtained by venipuncture (5-10 mL) and collected into heparinised 
tubes, for genotoxicity testing. All blood samples were coded, cooled (4°C), and processed 
within 2 hours after collection.  
 
Sister Chromatid Exchanges Assay  
SCEs assay was performed according to Santovito et al. (2014a). In order to determine the 
number of SCE/cell for each subject, we scored 50 well-spread second-division metaphases 
containing 46 (±1) chromosomes.  A total of 100 cells from each donor were scored for the 
determination of the replication index (RI), calculated according to the formula: RI =(M1 + 
2M2 + 3M3)/N, where M1, M2 and M3 represent the number of cells undergoing first, second, 
and third mitosis and N is the total number of metaphase scored. 
 
Chromosomal Aberrations Assay  
CAs assay was performed according to Santovito et al. (2011). For each subject, 200 well-
spread first-division complete metaphases were analysed for the following categories of CAs: 
chromatid breaks (B’), chromosome breaks (B”), dicentrics (Dic), acentric fragments (AF), 
rings (R) and tri- or tetra-radials (TR). Cells containing any type of chromosomal aberrations 
were scored as "aberrant cell” (Ab.C).   
 
DNA Isolation and PCR Analysis 
DNA extraction was conducted using the Chelex protocol as described in Walsh et al. (1991) 
modified: 10 µL of peripheral blood was diluted in 1 mL of sterile distilled water for 15 min 
at room temperature. After centrifugation at 14,000 rpm for 1 min, the pellet was re-
suspended in 200 µL of 5% Chelex solution in Tris-EDTA at pH 8, heated to 56°C for 15 min 
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and, after vortex for 10 sec, at 100°C in boiler water for 8 min. For PCR reactions we used 19 
µL of this solution containing extracted DNA. 
All subjects were genotyped for GSTT1, GSTM1, CYP1A1, XPD (A751C) and XPC (A939C) 
using primers and methodologies as described in Pemble et al., (1994), Zhong et al. (1993), 
Chen et al. (2001), Li et al. (2009) and Zhibian et al. (2005), respectively. PCR reactions 
were performed in a 25 µL volume containing about 10 ng DNA (template), with a final 
concentration of 1X Reaction Buffer, 1.5 mM of MgCl2, 5% of DMSO, 250 µM of dNTPs, 
0.5 µM of each primer, and 1 U/sample of Taq DNA polymerase (Fischer, U.S.). Cycles were 
set as follows: 35 cycles, 1 min at 95°C, 1 min at 60°C, 1 min at 72°C, and a final extension 
step 10 min at 72 °C. Amplification products were detected by ethidium bromide staining 
after 3% agarose gel electrophoresis.  
Statistical analysis 
Statistical analysis was assessed using the SPSS software statistical package programme 
(version 22.0, Chicago, USA). Differences between gender, mean age and years of 
employment among and between groups were evaluated by analysis of variance. A non-
parametric Wilcoxon Mann-Whitney U test was used to compare the mean frequencies of 
SCEs and CAs between groups and the possible association between gene polymorphisms 
and the level of genomic damage. Multiple regression analysis was used to evaluate the 
influence of age and years of exposure on SCEs and CAs frequencies of both groups. All P-
values were two tailed and the level of statistical significance was set at P<0.05 for all tests. 
 
Results 
Study population 
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Demographic characteristics of exposed and control populations involved in the study are 
reported in Table 1. Sixty pathologists (31 males and 30 females, mean age 42.557±8.619, 
range 25-60) and 60 control subjects (29 males and 31 females, mean age 40.300±8.988, 
range 24-60) were recruited in this study. The mean years of employment were 11.066±7.720 
for pathologists (range 1-33) and 12.317±7.331 for controls (range 1-32). No significant 
differences were found between pathologists and controls in terms of mean age (P = 0.119) 
and mean years of employment (P = 0.306).  
 
SCEs assay 
Results of SCEs assay are shown in Table 2. Significant differences were found between 
pathologists and controls in terms of SCEs frequency (P =0.001) and RI value (P<0.001). 
Among pathologists, the SCEs frequency did not correlate with years of occupational 
exposure (P = 0.857) nor with age (P = 0.814). Vice versa, among controls, a significant 
correlation was found between SCEs frequency, years of employment  (P =0.000) and age (P 
= 0.000) (Table 6). 
No gender differences were found in the pathologist group in terms of SCEs frequency (P = 
0.821) and RI value (P = 0.276), whereas in the control group males showed significant 
higher values of SCEs (P = 0.022) but not of RI (P = 0.141).  
 
CAs assay 
Results of CAs assay are shown in Table 3. We found 5 types of aberrations: chromatid 
breaks, chromosome breaks, dicentrics, acentric fragments, and tri-tetra-radial. The most 
frequent types of aberration were chromatid breaks and chromosome breaks. Significant 
differences were observed between pathologists and controls in the frequency of CAs/Cell 
and CAB/Cell (P <0.001). Among pathologists the level of chromosomal damage did not 
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correlate neither with years of employment (P = 0.118) nor with age (P = 0.410). Vice versa, 
in the control group years of employment and age significantly correlate with the frequency 
of CAs (P = 0.003 for both) (Table 6). Finally, among pathologists, no gender differences 
were found in terms of CAs and CAB frequencies (P = 0.288 and P = 0.450, respectively), 
whereas in the control group females showed significantly higher frequency of aberrant cells 
(P = 0.039). 
 
Gene polymorphisms and genomic damage 
Data about the association between analysed gene polymorphisms and genomic damage, 
measured in terms of SCEs and CAs frequencies, are reported in Tables 4 and 5, respectively.  
In the control group, no association was found between all analysed gene polymorphisms and 
the frequencies of SCEs and CAs. Vice versa, among pathologists, GSTT1 null genotypes 
showed a significantly higher frequency of SCEs, CAs and CAB (P = 0.026, P = 0.015 and P 
= 0.020, respectively) (Tables 4 and 5) and homozygote individuals for the XPD codon 751 C 
and XPC C alleles showed significantly higher frequencies of SCEs (P = 0.003, P = 0.043 
and P = 0.028, respectively) with respect to homozygote wild type subjects (Table 4). 
 
Discussion 
In the present study we evaluated, in a sample of hospital pathologists, the possible genomic 
damage associated with the occupational exposure to low levels of xenobiotics. Moreover, 
we examined the relationship between some metabolic and DNA-repair gene polymorphisms 
and the frequencies of SCEs and CAs.  
As general result, pathologists showed significantly higher frequencies of SCEs and CAs 
with respect to control subjects. These data further confirm the results obtained in our 
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previously published articles and those of other authors, placing hospital workers as risk 
category of genotoxic damage caused by chronic exposure to environmental xenobiotics 
(Fransman et al., 2004; Kopjar et al., 2009; Santovito et al., 2011; 2014a,b). The significantly 
lower RI value observed among pathologists indicates that this category of workers is also 
susceptible to cytotoxic risk. Pathologists might be exposed to chemicals throughout their use 
in health care environments and this occupational exposure may occur in different ways, such 
as inhalation of airborne agents, absorption through skin contact or contact with the patient’s 
body fluids (Ziegler et al., 2002; Santovito et al., 2014a).  
Among pathologists, analysing the possible relationship between metabolic gene 
polymorphisms and the level of genomic damage, we found a significant statistical 
association between GSTT1 null genotype and significantly higher frequencies of SCEs and 
CAs. This result confirms previous published data showing GSTT1 null genotype associated 
with increased frequencies of DNA adducts, SCEs and CAs in lymphocytes (Schröder et al., 
1995; Landi et al., 1996; Yi et al., 2007). In the control group we did not observe the same 
association, probably because of lower background levels of the analysed cytogenetic 
biomarkers. Also for the phase I CYP1A1 gene polymorphism the recessive G allele seem to 
be associated to an higher frequency of SCEs, although it was evident only among 
heterozygote AG individuals, probably due to the relative low number of recessive GG 
individuals found in our sample.  
 
Interesting, among pathologists, analysing the effect of the DNA-repair gene polymorphisms 
on the amount of genomic damage, we found an association between XPD 751 and XPC 15 
CC genotypes and increased levels of SCEs. It is known that high frequencies of SCEs are 
related to defects in the DNA-repair machinery (Garcia-Sagredo, 2008). At the same time, 
the XPD codon 751 C allele was found associated to lower DNA repair capacity and higher 
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levels of DNA adducts and chromatid aberrations (Lunn et al., 2000; Matullo et al., 2003; Ma 
et al., 2013). XPD gene has been shown to play a role in environmentally induced cancer 
(Goode et al., 2002) and, in particular, the homozygous CC variant genotype has been 
associated with a higher risk of head and neck cancer (Sturgis et al., 2000).  
Finally, XPC gene is critical for the cells to complete excision repair of bulky DNA lesions 
being its product involved in the DNA damage recognition and DNA repair initiation in the 
NER pathway (Berneburg and Lehmann 2001; Thoma 2003). Amongst all known SNPs of 
XPC gene, the A939C (Lys>Gln) was found to be associated with a reduced DNA repair 
capacity in peripheral lymphocytes and higher levels of chromosomal aberrations (Vodicka et 
al., 2004). In this scenario, homozygote CC genotypes could show a lower DNA repair 
efficiency and consequently higher levels of SCEs as observed in our sample. This higher 
level of genomic damage could be related to increase risk of cancer after exposure to 
environmental xenobiotics. Indeed the C allele was found associated with increased risk of 
lung cancer in a Danish population (Vogel et al., 2005) and bladder cancer in a Swedish 
population (Senyal et al., 2004).         
                                                                                           
Conclusions 
We found increased levels of genomic damage in a sample of hospital pathologists. Our 
results and those obtained by other authors emphasize the importance of the biomonitoring of 
pathologists and other hospital workers during their work routine. An association between 
metabolic and DNA-repair gene polymorphisms and the level of genomic damage was also 
observed. These data further confirm the importance of the individual genomic background in 
the response to environmental xenobiotics induced damage, as well as the importance of the 
genetic polymorphisms analysis associated to genotoxicological studies.  
 
Page 13 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Declaration of Interest 
The authors report no declarations of interest. 
 
Acknowledgments  
The authors report no conflicts of interest.  
This investigation was supported by a grant from University of Turin (grant ex 60%).  
 
References 
Au WW, Navasumrit P, Ruchirawat M. (2004). Use of biomarkers to characterize 
functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health 
207:301-313. 
Autrup H. (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes 
as susceptibility factors in toxic response. Mutat Res 464:65-76. 
Berneburg M, Lehmann AR. (2001). Xeroderma pigmentosum and related disorders: 
defects in DNA repair and transcription. Adv Genet 43:71-102. 
Berwick M, Vineis P. (2000). Markers of DNA repair and susceptibility to cancer in 
humans: an epidemiologic review. J Natl Cancer Inst 92(11):874-897 
Bonassi S, Znaor A, Norppa H, Hagmar L. (2004). Chromosomal aberrations and risk of 
cancer in humans: an epidemiologic perspective. Cytogenet Gen Res, 104:376-
382. 
Chen S, Xue K, Xu L, Ma G, Wu J. (2001). Polymorphisms of the CYP1A1 and GSTM1 
genes in relation to individual susceptibility to lung carcinoma in Chinese 
population. Mutat Res 458:41-47. 
Cleaver JE, Lam ET, Revet I. (2009). Disorders of nucleotide excision repair: the genetic 
and molecular basis of heterogeneity. Nature, 10:756-768. 
Page 14 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Collins AR, Azqueta A. (2012). DNA repair as a biomarker in human biomonitoring 
studies: further applications of the comet assay. Mutat Res 736:122-129. 
Donner EM, Wong BA, James RA, Preston RJ. (2010). Reciprocal translocations in 
somatic and germ cells of mice chronically exposed by inhalation to ethylene 
oxide: implications for risk assessment. Mutagenesis 25(1):49-55.  
Fransman W, Vermuelen R and Kromhout H. (2004). Occupationel dermal exposure to 
cyclophosphamide in Dutch hospitals: a pilot study. Ann Occup Hyg 48:237-44. 
Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, 
Zientek H, Hemminki K, Kumar R. (2004). Single nucleotide polymorphisms in 
breast cancer. Oncol Rep 11: 917-922. 
Garcia-Sagredo JM. (2008). Fifty years of cytogenetics: a parallel view of the evolution 
of cytogenetics and genotoxicology. Biochim Biophys Acta 1779(6-7):363-75. 
Goode EL, Ulrich CM, Potter JD. (2002). Polymorphisms in DNA repair genes and 
associations with cancer risk. Cancer Epidemiol Biom Prev 11:1513-1530. 
Haufroid V, Merz B, Hofmann A, Tschopp A, Lison D, Hotz P. (2007). Exposure to 
Ethylene Oxide in Hospitals: Biological Monitoring and Influence of Glutathione 
S-Transferase and Epoxide Hydrolase Polymorphisms. Cancer Epidem Biom Prev 
16:796-802. 
International Agency for Research on Cancer (IARC). (2006). Formaldehyde, 2-
butoxyethanol and 1-tert-butoxypropan-2-ol. Lyon. IARC Monogr Eval Carcinog 
Risks Hum 88:1–478 
International Agency for Research on Cancer (IARC). (2007). 1,3-Butadiene, Ethylene 
Oxide and Vinyl Halides (Vinyl Fluoride,Vinyl Chloride and Vinyl Bromide). 
IARC Monogr Eval Carcinog Risks Hum 97:185-288 
Page 15 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Khlifi R, Rebai A, Hamza-Chaffai A. (2012). Polymorphisms in human DNA repair 
genes and head and neck squamous cell carcinoma. J Genet 91(3):375-384. 
Kopjar N, Garaj-Vrhocav V, Kasŭba V, Rozgaj R, Ramić S, Pavlica V, Zeljezić D. 
(2009). Assessment of genotoxic risks in Croatian healthcare workers 
occupationally exposed to cytotoxic drugs: a multi-biomarker approach. Int J Hyg 
Environ Health 212(4):414-431. 
Landi S, Ponzanelli I, Hirvonen A, Norppa H and Barale R. (1996). Repeated analysis of 
sister chromatid exchange induction by diepoxybutane in cultured human 
lymphocytes: effect of glutathione S-transferases T1 and M1 genotype. Mutat Res 
351:79-85. 
Li Y, Marion M-J, Zipprich J, Santella RM, Freyer G and Brandt-Rauf PW. (2009). 
Gene-environment interactions between DNA repair polymorphisms and exposure 
to the carcinogen vinyl chloride. Biomarkers 14(3):148-155. 
Lorenti Garcia C, Darroudi F, Tates AD, Natarajan AT. (2001). Induction and persistence 
of micronuclei, sister-chromatid exchanges and chromosomal aberrations in 
splenocytes and bone-marrow cells of rats exposed to ethylene oxide. Mutat Res 
492(1-2):59-67. 
Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. 
(2000). XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis  
21:551-555. 
Ma Q, Qui C, Tie C, Guo Z. (2013). Genetic polymorphisms of xeroderma pigmentosum 
group D gene Asp312 Asn and Lys751Gln and susceptibility to prostate cancer: a 
systematic review and meta-analysis. Gene 530(2):309-314. 
Matullo G, Peluso M, Polidoro S, Guarrera S, Munnia A, Krogh V, Masala G, Berrino F, 
Panico S, Tumino R, Vineis P, Palli D. (2003). Combination of DNA repair gene 
Page 16 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
single nucleotide polymorphisms and increased levels of DNA adducts in a 
population-based study. Cancer Epidemiol Biom Prev 12:674-677. 
McHugh PJ, Spanswick VJ, Hartley JA. (2001). Repair of DNA interstrand crosslinks: 
molecular mechanisms and clinical relevance. Lancet Oncol 2(8):483-90. 
Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor 
JB. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and 
the characterization of a genetic polymorphism. Biochem J 300:271-276. 
Santovito A, Schilirò T, Castellano S, Cervella P, Bigatti MP, Gilli G, Bono R, Delpero 
M. (2011). Combined analysis of chromosomal aberrations and glutathione S-
transferase M1 and T1 polymorphisms in pathologists occupationally exposed to 
formaldehyde. Arch Toxicol 85:1295-1302. 
Santovito A, Cervella P, Delpero M. (2014 a). Chromosomal damage in peripheral blood 
lymphocytes from nurses occupationally exposed to chemicals. Hum Exp Toxicol 
33(9)897-903. 
Santovito A, Cervella P, Delpero M. (2014 b). Increased frequency of chromosomal 
aberrations and sister chromatid exchanges in peripheral lymphocytes of radiology 
technicians chronically exposed to low levels of ionizing radiations. Environ 
Toxicol Pharmacol 37:396-403. 
Santovito A, Cervella P, Delpero M. (2015). Evaluation of Genomic Damage in 
Peripheral Lymphocytes from Occupationally Exposed Anesthetists: Assessment 
of the Effects of Age, Sex, and GSTT1 Gene Polymorphism. J Biochem Mol 
Toxic 29(5): 234-239. 
Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkstrom H, Larsson P, 
Kumar R, Hemminki K. (2004). Polymorphisms in DNA repair and metabolic 
genes in bladder cancer. Carcinogenesis 25:729–34. 
Page 17 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Schröder KR, Wiebel FA, Reich S, Dannappel D, Bolt HM, Hallier E. (1995). 
Glutathione-S-transferase (GST) theta polymorphism influences background SCE 
rate. Arch Toxicol 69:505-507. 
Sierra-Torres MS, Arboleda-Moreno YY, Hoyos LS, Sierra-Torres CH. (2004). 
Chromosome aberrations among cigarette smokers in Colombia. Mutat Res 562(1-
2):67-75. 
Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR, Wei 
Q. (2000). XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case–
control analysis. Carcinogenesis 21:2219-2223. 
Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, 
Bootsma D, Hoeijmakers JH. (1998). Xeroderma pigmentosum group C protein 
complex is the initiator of global genome nucleotide excision repair. Mol Cell 
2:223-32. 
Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Japsers NGJ, Fawcett H, 
Harcourt SA, Arlett CF, Lehmann AR. (1997). Xeroderma pigmentosum and 
trichothiodystrophy are associated with different mutations in the XPD (ERCC2) 
repair/transcription gene. Proc Natl Acad Sci USA 94:8658-8663. 
Thoma B. (2003). Critical DNA damage recognition functions of XPChHR23B and XPA-
RPA in nucleotide excision repair. Mol Carcinog 38:1-13. 
Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, Dusinska M, Kuricova 
M, Zamecnikova M, Musak L, Buchancova J, Norppa H, Hirvonen A, Vodickova 
L, Naccarati A, Matousu Z, Hemminki K. (2004). Genetic polymorphisms in 
DNA repair genes and possible links with DNA repair rates, chromosomal 
aberrations and single-strand breaks in DNA. Carcinogenesis 25:757-63. 
Page 18 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Vogel U, Overvad K, Wallin H, Tjonneland A, Nexo BA, Raaschou-Nielsen O. (2005). 
Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung 
cancer. Cancer Lett 222:67–74. 
Walsh PS, Metzger DA, Higuchi R. (1991). Chelex 100 as a Medium for simple 
extraction of DNA for PCR-based typing from forensic material. BioTechniques 
10:506-513. 
Wang Q, Ji F, Sun Y, Qui YL, Wang W, Wu F, Miao W, Li Y, , Brandt-Rauf PW and Xia 
Z .(2010). Genetic polymorphisms of XRCC1, HOGG1 and MGMT and 
micronucleus occurrence in Chinese vinyl chloride-exposed workers. 
Carcinogenesis 31(6):1068-1073. 
Wang Q, Tan HS, Zhang F, Sun Y, Feng N, Zhou L, Ye Y,  Zhu Y, Li Y, Brandt-Rauf 
PW, Shao H. (2013). Polymorphisms in BER and NER pathway genes: Effects on 
micronucleus frequencies among vinyl chloride-exposed workers In northern 
China. Mutat Res 754:7-14. 
Winkler GS, Araújo SJ, Fiedler U, Vermeulen W, Coin F, Egly JM, Hoeijmakers JHJ, 
Wood RD, Timnmers HTM, Weeda G. (2000). TFIIH with inactive XPD helicase 
functions in transcription initiation but is defective in DNA repair. J Biol Chem 
275(6):4258-4266 
Yi B, Yang JY, Yang M. (2007). Past and future applications of CYP450-genetic 
polymorphisms for biomonitoring of environmental toxicants. J Environ Sci 
Health C Environ Carcinog Ecotoxicol Rev 25(4):353-377. 
Ziegler E, Manson HJ and Baxter PJ. (2002). Occupational exposure to cytotoxic drugs in 
two UK oncology wards. Occup Environ Med 59(9):608-612. 
Page 19 of 26
URL: http://mc.manuscriptcentral.com/tbmk  Email: cleo.hall@informa.com
Biomarkers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Table 1 – Demographic characteristics of the studied groups 
Characteristics Pathologists Controls 
Subjects 61 60 
Sex 
 
Males 
Females 
 
 
31 
30 
 
 
29 
31 
Age 
 
Total sample 
Mean years ± S.D. 
Range (years) 
 
Males 
Mean years ± S.D. 
Range (years) 
Females 
 
Mean years ± S.D. 
Range (years) 
 
 
 
42.557±8.619 
25-60 
 
 
45.710±8.726 
28-60 
 
 
37.161±7.038 
25-53 
 
 
 
40.300±8.988 
24-60 
 
 
44.000±10.474 
27-60 
 
 
37.161±7.038 
24-53 
Years of employment 
 
Total sample 
Mean years ± S.D. 
Range (years) 
 
Males 
Mean years ± S.D. 
Range (years) 
 
Females 
Mean years ± S.D. 
Range (years) 
 
 
 
11.066±7.720 
1-33 
 
 
14.323±7.893 
2-33 
 
 
7.700±5.984 
1-27 
 
 
 
12.317±7.331 
1-32 
 
 
14.931±8.811 
2-31 
 
 
9.871±3.648 
1-20 
S.D. = Standard Deviation 
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Table 2 - Frequency of SCEs and RI values in metaphases of lymphocytes from studied subjects 
Groups N Cells SCEs SCEs/Cell ± S.E M1 M2 M3 RI ± S.E. 
Pathologists 61 3050 16041 5.259±0.167
a 
2710 2274 1015 1.705±0.041
b
 
Males 
Females 
31 
30 
1550 
1500 
8289 
7752 
5.348±0.202 
5.168±0.271 
1325 
1385 
1165 
1109 
556 
459 
1.746±0.065 
1.661±0.050 
Controls 60 3000 13068 4.356±0.205
a
 2047 2379 1562 1.900±0.026
b
 
Males 
Females 
29 
31 
1450 
1550 
7081 
5987 
4.883±0.247 
c
 
3.863±0.300 
c
 
1026 
1021 
1144 
1235 
733 
829 
1.911±0.032 
1.950±0.039 
a
P = 0.001; 
b
P <0.001; 
c
P = 0.022 
N = Number of analysed subjects; SCEs = Sister chromatid exchanges; RI (Replication Index) = 
(M1 + 2M2 + 3M3)/N, where M1, M2 and M3 represent the number of cells   undergoing first second 
and third mitosis and N is the total number of metaphase scored; S.E. = Standard Error;  
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Table 3 - Frequencies of chromosomal aberrations (CAs) and cells with aberrations (Ab.C) in in 
metaphases of lymphocytes from studied subjects 
Groups 
CAs 
N Cells B’ B” Dic AF TR 
Total 
CAs 
Total 
Ab.C 
CAs/Cell % 
mean±S.E. 
Ab.C/Cell % 
mean±S.E. 
Pathologists 
Males 
Females 
61 
31 
30 
12200 
6200 
6000 
133 
78 
55 
28 
13 
15 
6 
1 
5 
21 
14 
7 
1 
0 
4 
189 
106 
83 
178 
97 
81 
0.0155±0.001
a
 
0.017±0.002 
0.014±0.002 
0.0146±0.001
b
 
0.016±0.002 
0.014±0.002 
Controls 
Males 
Females 
60 
29 
31 
12000 
5800 
6200 
51 
14 
37 
11 
6 
5 
5 
2 
3 
17 
6 
11 
4 
2 
2 
88 
30 
58 
87 
29 
58 
0.007±0.001
a 
0.005±0.001
 
0.009±0.001 
0.007±0.001
b 
0.005±0.001
c 
0.009±0.001
c
 
 a,b
P  <0.001;
 c
P = 0.039  
B’: chromatid breaks; B”: chromosome breaks; Dic = Dicentric chromosome; AF = Acentric 
Fragments; R = Rings; TR = Tri- or Tetra-Radials; CAs = Chromosome Aberrations; Ab.C = cells 
with aberrations; S.E. = Standard Error. 
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Table 4 - Frequency of SCEs and RI values in metaphases of lymphocytes from studied subjects according to gene  
polymorphisms. Significant results have been highlighted in bold. 
Subjects N Cells SCEs 
SCEs/Cells 
± S.E 
M1 M2 M3 RI ± S.E. 
PAT - GSTT1 
Positive 
Null 
 
46 
16 
 
2250 
800 
 
11777 
4264 
 
5.234±0.193 
a
 
5.330±0.344 
a
 
 
2044 
666 
 
1630 
644 
 
779 
236 
 
1.715±0.053 
1.676±0.053 
PAT - GSTM1 
Positive 
Null 
 
50 
11 
 
2500 
550 
 
13125 
2916 
 
5.250±0.177 
5.302±0.479 
 
2258 
452 
 
1798 
476 
 
822 
193 
 
1.702±0.045 
1.717±0.109 
PAT - CYP1A1 exon 7 
AA 
AG 
GG 
 
31 
27 
3 
 
1550 
1350 
150 
 
7562 
7770 
709 
 
4.879±0.238 
b
 
5.756±0.225 
b
 
4.727±0.591 
 
1412 
1191 
107 
 
1036 
1091 
147 
 
583 
386 
46 
 
1.720±0.068 
1.676±0.050 
1.797±0.138 
PAT - XPD cod 751  
AA 
AC 
CC 
 
37 
13 
11 
 
1850 
650 
550 
 
9064 
3479 
3498 
 
4.899±0.190 
c
 
5.352±0.414 
 
6.360±0.291 
c
 
 
1664 
569 
477 
 
1346 
538 
390 
 
608 
183 
224 
 
1.705±0.056 
1.648±0.089 
1.770±0.084 
PAT - XPC exon 15  
AA 
AC 
CC 
 
19 
35 
7 
 
950 
1750 
350 
 
4771 
9362 
1908 
 
5.022±0.329 
d
 
5.350±0.224  
5.451±0.313 
d
 
 
861 
1588 
261 
 
740 
1288 
246 
 
248 
584 
183 
 
1.631±0.052 
1.708±0.060  
1.889±0.129 
CONTR - GSTT1 
Positive 
Null 
 
38 
22 
 
1900 
1100 
 
8583 
4485 
 
4.517±0.277 
4.077±0.286 
 
1343 
704 
 
1499 
880 
 
946 
616 
 
1.909±0.030 
1.955±0.040 
CONTR - GSTM1 
Positive 
Null 
 
24 
36 
 
1200 
1800 
 
5909 
7159 
 
4.924±0.314 
3.977±0.254 
 
852 
1195 
 
972 
1407 
 
562 
1000 
 
1.878±0.035 
1.957±0.190 
CONTR - CYP1A1 exon 7 
AA 
AG 
GG 
 
45 
12 
3 
 
2250 
600 
150 
 
10234 
2333 
501 
 
4.548±0.246 
3.888±0.384 
3.340±0.592 
 
1503 
438 
106 
 
1831 
436 
112 
 
1153 
327 
82 
 
1.930±0.025 
1.912±0.065 
1.920±0.012 
CONTR - XPD cod 751  
AA 
 
45 
 
2250 
 
10589 
 
4.706±0.230 
 
1551 
 
1824 
 
1113 
 
1.884±0.020 
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AC 
CC 
9 
6 
450 
300 
1606 
873 
3.569±0.462 
2.910±0.390 
345 
151 
324 
231 
231 
218 
2.008±0.075 
2.112±0.094 
CONTR - XPC exon 15 
AA 
AC 
CC 
 
24 
32 
4 
 
1200 
1600 
200 
 
5255 
7263 
550 
 
4.379±0.345 
4.539±0.264 
2.750±0.482 
 
796 
1112 
139 
 
960 
1291 
128 
 
634 
795 
133 
 
1.932±0.040 
1.893±0.028 
2.153±0.104 
a
P = 0.026; 
b,c
 P = 0.003; 
e
 P = 0.028;
 
 
PAT = Pathologists; CONTR = Controls; N = Number of analysed subjects; SCEs = Sister chromatid exchanges;  
RI (Replication Index) = (M1 + 2M2 + 3M3)/N, where M1, M2 and M3 represent the number of cells undergoing first  
second and third mitosis and N is the total number of metaphase scored; S.E. = Standard Error;  
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Table 5 - Frequencies of chromosomal aberrations (CAs) and cells with aberrations (Ab.C) in lymphocytes of studied subjects, according to gene 
polymorphisms. Significant results have been highlighted in bold. 
 
Subjects N Cells B’ B’’ Dic AF TR 
Total 
CAs 
Total 
Ab.C 
CAs/Cells 
mean±S.E. 
Ab.C/Cells 
mean±S.E. 
PAT - GSTT1 
Positive 
Null 
45 
16 
9000 
3200 
86 
47 
18 
10 
4 
2 
13 
8 
1 
0 
122 
67 
114 
64 
0.014±0.001 
a
 
0.021±0.004 
a
 
0.013±0.001 
b
 
0.020±0.004 
b
 
PAT - GSTM1 
Positive 
Null 
 
50 
11 
 
10000 
2200 
 
109 
24 
 
25 
3 
 
4 
2 
 
20 
1 
 
1 
0 
 
159 
30 
 
152 
26 
 
0.016±0.002 
0.014±0.004 
 
0.015±0.002 
0.012±0.002 
PAT - CYP1A1 exon 7 
AA 
AG 
GG 
 
31 
27 
3 
 
6200 
5400 
600 
 
58 
68 
7 
 
12 
14 
2 
 
4 
2 
0 
 
13 
8 
0 
 
0 
1 
0 
 
87 
93 
9 
 
81 
88 
9 
 
0.014±0.002 
0.017±0.002 
0.015±0.013 
 
0.013.±0.002 
0.016±0.002 
0.015±0.013 
PAT - XPD cod 751  
AA 
AC 
CC 
 
37 
13 
11 
 
7400 
2600 
2200 
 
82 
28 
23 
 
21 
3 
4 
 
3 
2 
1 
 
15 
4 
2 
 
1 
0 
0 
 
122 
37 
30 
 
115 
37 
26 
 
0.016±0.002 
0.014±0.003 
0.014±0.002 
 
0.016±0.002 
0.014±0.003 
0.012±0.002 
PAT - XPC exon 15  
AA 
AC 
CC 
 
19 
35 
7 
 
3800 
7000 
1400 
 
35 
84 
14 
 
6 
20 
2 
 
1 
4 
1 
 
9 
9 
3 
 
1 
0 
0 
 
52 
117 
20 
 
51 
107 
20 
 
0.014±0.002 
0.017±0.002 
0.014±0.004 
 
0.013±0.002 
0.015±0.002 
0.014±0.004 
CONTR - GSTT1 
Positive 
Null 
 
38 
22 
 
7600 
4400 
 
29 
22 
 
5 
6 
 
3 
2 
 
9 
8 
 
2 
2 
 
48 
40 
 
48 
39 
 
0.006±0.001 
0.009±0.002 
 
0.006±0.001 
0.009±0.002 
CONTR - GSTM1 
Positive 
Null 
 
24 
36 
 
4800 
7200 
 
13 
37 
 
1 
10 
 
0 
5 
 
8 
9 
 
0 
4 
 
23 
65 
 
23 
64 
 
0.005±0.001 
0.009±0.001 
 
0.005±0.001 
0.009±0.001 
CONTR - CYP1A1 exon 7 
AA 
AG 
GG 
 
45 
12 
3 
 
9000 
2400 
600 
 
28 
18 
5 
 
5 
5 
1 
 
3 
2 
0 
 
15 
1 
1 
 
0 
2 
2 
 
51 
28 
9 
 
50 
28 
9 
 
0.006±0.001 
0.012±0.002 
0.015±0.000 
 
0.006.±0.001 
0.012±0.002 
0.015±0.000 
CONTR - XPD cod 751             
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AA 
AC 
CC 
45 
9 
6 
9000 
1800 
1200 
32 
12 
7 
7 
2 
2 
3 
1 
1 
14 
2 
1 
2 
1 
1 
58 
18 
12 
57 
18 
12 
0.006±0.001 
0.010±0.003 
0.010±0.003 
0.006±0.001 
0.010±0.003 
0.010±0.003 
CONTR - XPC exon 15 
AA 
AC 
CC 
 
24 
32 
4 
 
4800 
6400 
800 
 
23 
21 
7 
 
4 
6 
1 
 
1 
4 
0 
 
8 
9 
0 
 
3 
1 
0 
 
39 
41 
8 
 
39 
40 
8 
 
0.008±0.001 
0.006±0.001 
0.010±0.002 
 
0.008±0.001 
0.006±0.001 
0.010±0.002 
a
P = 0.015; 
b
P = 0.020 
PAT = Pathologists; CONTR = Controls; N = Number of analysed subjects; B’: chromatid breaks; B”: chromosome breaks; Dic = Dicentric 
chromosome; AF = Acentric Fragments; R = Rings; TR = tri- or tetra-radials; CAs = Chromosome Aberrations; Ab.C = cells with aberrations; S.E. = 
Standard Error. 
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Table 6. Multiple regression analysis of confounding factors on SCEs and CAs frequencies in 
lymphocytes of the study groups 
 
SCEs frequency CAs frequency 
CF β-co P-value 95% CI 
(Lower) – (Upper) 
β-co P-value 95% CI 
(Lower) – (Upper) 
Pathologists 
Age 
Y.E. 
 
-0.031 
-0.024 
 
0.814 
0.857 
 
(-2.206) – (1.740) 
(-2.403) – (2.003) 
 
0.107 
0.202 
 
0.410 
0.118 
 
(-0.039) – (0.095) 
(-0.015 – (0.132) 
Controls 
Age 
Y.E. 
 
0.589 
0.473 
 
0.000 
0.000 
 
(3.162) – (6.736) 
(2.612) – (7.628) 
 
-0.372 
-0.383 
 
0.003 
0.003 
 
(-0.083) – (0.017) 
(-0.108) – (0.024) 
CF = Confounding Factor; β-co = β-coefficient; Y.E. = years of employment 
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